3 results
424B5
IPHA
Innate Pharma
6 Feb 24
Prospectus supplement for primary offering
5:00pm
on the dividend net of the expenses incurred for the acquisition and conservation directly related to the income, provided (i) that these expenses would
424B5
IPHA
Innate Pharma
26 Apr 23
Prospectus supplement for primary offering
4:01pm
on the dividend net of the expenses incurred for the acquisition and conservation directly related to the income, provided (i) that these expenses
- Prev
- 1
- Next